Over-expression of thymosin β4 in granulomatous lung tissue with active pulmonary tuberculosis

Tuberculosis

Volumn 94, Issue 3, 2014, Pages 323-331

  Kang, Yun Jeong ^a   Jo, Jin Ok ^a   Ock, Mee Sun ^a   Yoo, Young Bin ^b   Chun, Bong Kwon ^a   Oak, Chul Ho ^a   Cha, Hee Jae ^a  

^a Kosin University College of Medicine   (South Korea)

^b Konyang University   (South Korea)

Author keywords

HIF; Inflammation; Thymosin 4; Tuberculosis; VEGF

Indexed keywords

CD31 ANTIGEN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; THYMOSIN BETA4; VASCULOTROPIN; BIOLOGICAL MARKER; THYMOSIN; THYMOSIN BETA(4); VASCULOTROPIN A;

ARTICLE; BLOOD VESSEL; CLINICAL ARTICLE; CONTROLLED STUDY; GENE OVEREXPRESSION; GRANULOMA; GRANULOMATOSIS; HUMAN; HUMAN TISSUE; LUNG ALVEOLUS MACROPHAGE; LUNG PARENCHYMA; LUNG TUBERCULOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPUTUM; TISSUE MICROARRAY; FLUORESCENT ANTIBODY TECHNIQUE; LUNG; LUNG GRANULOMA; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUBERCULOSIS, PULMONARY; VASCULARIZATION;

BIOLOGICAL MARKERS; FLUORESCENT ANTIBODY TECHNIQUE; GRANULOMA, RESPIRATORY TRACT; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LUNG; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPUTUM; THYMOSIN; TUBERCULOSIS, PULMONARY; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84900825548     PISSN: 14729792     EISSN: 1873281X     Source Type: Journal    
DOI: 10.1016/j.tube.2014.01.003     Document Type: Article

References (31)

1. A. Kochi The global tuberculosis situation and the new control strategy of the World Health Organization Bull World Health Organ 2001 79 1991 71 75
2. O.A. El-Zammar, and A.L. Katzenstein Pathological diagnosis of granulomatous lung disease: a review Histopathology 50 2007 289 310
3. B.M. Saunders, and W.J. Britton Life and death in the granuloma: immunopathology of tuberculosis Immunol Cell Biol 85 2007 103 111
4. W. Matsuyama, T. Hashiguchi, K. Matsumuro, F. Iwami, Y. Hirotsu, M. Kawabata, K. Arimura, and M. Osame Increased serum level of vascular endothelial growth factor in pulmonary tuberculosis Am J Respir Crit Care Med 162 2000 1120 1122
5. W. Matsuyama, T. Hashiguchi, F. Umehara, E. Matsuura, M. Kawabata, K. Arimura, I. Maruyama, and M. Osame Expression of vascular endothelial growth factor in tuberculous meningitis J Neurol Sci 186 2001 75 79
6. F. Alatas, O. Alatas, M. Metintas, A. Ozarslan, S. Erginel, and H. Yildirim Vascular endothelial growth factor levels in active pulmonary tuberculosis Chest 125 2004 2156 2159
7. S. Ragno, M. Romano, S. Howell, D.J. Pappin, P.J. Jenner, and M.J. Colston Changes in gene expression in macrophages infected with Mycobacterium tuberculosis: a combined transcriptomic and proteomic approach Immunology 104 2001 99 108
8. M. Seiscento, F.S. Vargas, M.M. Acencio, L.R. Teixeira, V.L. Capelozzi, R.K. Sales, and L. Antonangelo Pleural fluid cytokines correlate with tissue inflammatory expression in tuberculosis Int J Tuberc Lung Dis 14 2010 1153 1158
9. J. Liu, Y. Zeng, W. Ma, S. Chen, Y. Zheng, S. Ye, L. Lan, H.J. Weig, and Q. Liu Preliminary investigation of the clinical value of vascular endothelial growth factor and hypoxia-inducible factor-1alpha in pericardial fluid in diagnosing malignant and tuberculous pericardial effusion Cardiology 116 2010 37 41
10. H.J. Cha, M.J. Jeong, and H.K. Kleinman Role of thymosin beta4 in tumor metastasis and angiogenesis J Natl Cancer Inst 95 2003 1674 1680
11. D.S. Grant, W. Rose, C. Yaen, A. Goldstein, J. Martinez, and H. Kleinman Thymosin beta4 enhances endothelial cell differentiation and angiogenesis Angiogenesis 3 1999 125 135
12. J.O. Jo, S.R. Kim, M.K. Bae, Y.J. Kang, M.S. Ock, H.K. Kleinman, and H.J. Cha Thymosin beta4 induces the expression of vascular endothelial growth factor (VEGF) in a hypoxia-inducible factor (HIF)-1alpha-dependent manner Biochim Biophys Acta 1803 2010 1244 1251
13. T. Kobayashi, F. Okada, N. Fujii, N. Tomita, S. Ito, H. Tazawa, T. Aoyama, S.K. Choi, T. Shibata, H. Fujita, and M. Hosokawa Thymosin-beta4 regulates motility and metastasis of malignant mouse fibrosarcoma cells Am J Pathol 160 2002 869 882
14. L.I. Larsson, and S. Holck Occurrence of thymosin beta4 in human breast cancer cells and in other cell types of the tumor microenvironment Hum Pathol 38 2007 114 119
15. K.M. Malinda, A.L. Goldstein, and H.K. Kleinman Thymosin beta 4 stimulates directional migration of human umbilical vein endothelial cells FASEB J 11 1997 474 481
16. P. Qiu, M.K. Wheater, Y. Qiu, and G. Sosne Thymosin beta4 inhibits TNF-alpha-induced NF-kappaB activation, IL-8 expression, and the sensitizing effects by its partners PINCH-1 and ILK FASEB J 25 2011 1815 1826
17. Y. Zhang, L.W. Feurino, Q. Zhai, H. Wang, W.E. Fisher, C. Chen, Q. Yao, and M. Li Thymosin Beta 4 is overexpressed in human pancreatic cancer cells and stimulates proinflammatory cytokine secretion and JNK activation Cancer Biol Ther 7 2008 419 423
18. M. Badamchian, M.O. Fagarasan, R.L. Danner, A.F. Suffredini, H. Damavandy, and A.L. Goldstein Thymosin beta(4) reduces lethality and down-regulates inflammatory mediators in endotoxin-induced septic shock Int Immunopharmacol 3 2003 1225 1233
19. M. Girardi, M.A. Sherling, R.B. Filler, J. Shires, E. Theodoridis, A.C. Hayday, and R.E. Tigelaar Anti-inflammatory effects in the skin of thymosin-beta4 splice-variants Immunology 109 2003 1 7
20. J.D. Young, A.J. Lawrence, A.G. MacLean, B.P. Leung, I.B. McInnes, B. Canas, D.J. Pappin, and R.D. Stevenson Thymosin beta 4 sulfoxide is an anti-inflammatory agent generated by monocytes in the presence of glucocorticoids Nat Med 5 1999 1424 1427
21. N.S. Kim, Y.J. Kang, J.O. Jo, H.Y. Kim, Y.R. Oh, Y.O. Kim, M.H. Jung, M.S. Ock, and H.J. Cha Elevated expression of thymosin beta4, vascular endothelial growth factor (VEGF), and hypoxia inducible factor (HIF)-1alpha in early-stage cervical cancers Pathol Oncol Res 17 2011 493 502
22. J.O. Jo, Y.J. Kang, M.S. Ock, H.K. Kleinman, H.K. Chang, and H.J. Cha Thymosin beta4 expression in human tissues and in tumors using tissue microarrays Appl Immunohistochem Mol Morphol 19 2011 160 167
23. G. Walzl, K. Ronacher, W. Hanekom, T.J. Scriba, and A. Zumla Immunological biomarkers of tuberculosis Nat Rev Immunol 11 2011 343 354
24. M. Doherty, R.S. Wallis, and A. Zumla Biomarkers for tuberculosis disease status and diagnosis Curr Opin Pulm Med 15 2009 181 187
25. H. Shams, S.E. Weis, P. Klucar, A. Lalvani, P.K. Moonan, J.M. Pogoda, K. Ewer, and P.F. Barnes Enzyme-linked immunospot and tuberculin skin testing to detect latent tuberculosis infection Am J Respir Crit Care Med 172 2005 1161 1168
26. C.C. Whalen Diagnosis of latent tuberculosis infection: measure for measure J Am Med Assoc 293 2005 2785 2787
27. R.M. Jasmer, P. Nahid, and P.C. Hopewell Clinical practice. Latent tuberculosis infection N Engl J Med 347 2002 1860 1866
28. D.G. Russell, P.J. Cardona, M.J. Kim, S. Allain, and F. Altare Foamy macrophages and the progression of the human tuberculosis granuloma Nat Immunol 10 2009 943 948
29. R.L. Hunter Pathology of post primary tuberculosis of the lung: an illustrated critical review Tuberculosis 91 2011 497 509
30. M. Frohm, H. Gunne, A.C. Bergman, B. Agerberth, T. Bergman, A. Boman, S. Liden, H. Jornvall, and H.G. Boman Biochemical and antibacterial analysis of human wound and blister fluid Eur J Biochem 237 1996 86 92
31. N. Husain, S. Awasthi, M. Haris, R.K. Gupta, and M. Husain Vascular endothelial growth factor as a marker of disease activity in neurotuberculosis J Infect 56 2008 114 119